SCHEMBL20480211

SCHEMBL20480211

O=C(N[C@@H]1C[C@@H](CN2C(=O)c3ccccc3C2=O)N(C(=O)O)C1)OCc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.46
GAA P10253 1/20 0.46
CTSL P07711 1/20 0.46
CTSB P07858 1/20 0.46
CTSK P43235 1/20 0.46
TLR4 O00206 1/20 0.45
TSHR P16473 1/20 0.45
HSD11B1 P28845 1/20 0.43
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
RAB9A P51151 1/20 0.42
EPHX1 P07099 1/20 0.42
DPP4 P27487 4/20 0.41
DPP7 Q9UHL4 4/20 0.41
PREP P48147 2/20 0.41
CPB1 P15086 1/20 0.41
KCNH2 Q12809 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18342303 0.88 ABCB1 (0.46) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL18342301 0.88 ABCB1 (0.46) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL20479836 0.88 ABCB1 (0.46) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL376598 0.83 ALDH1A1 (0.53) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL21802063 0.83 ALDH1A1 (0.53) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL15265196 0.83 ALDH1A1 (0.53) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL29083371 0.83 ALDH1A1 (0.53) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL23632029 0.78 ALDH1A1 (0.47) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL21802086 0.78 ALDH1A1 (0.57) ALDH1A1GAACTSLCTSBCTSK
SCHEMBL25184490 0.78 ALDH1A1 (0.54) ALDH1A1GAACTSLCTSBCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3313832-B1 3-TETRAZOLYL-BENZENE-1,2-DISULFONAMIDE DERIVATIVES AS METALLO-BETA-LACTAMASE INHIBITORS MERCK SHARP & DOHME (US) 2021-02-24 EP disclosed
US-10221163-B2 Metallo-beta-lactamase inhibitors MERCK SHARP & DOHME CORP. (US) 2019-03-05 US disclosed
US-20180244656-A1 METALLO-BETA-LACTAMASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2018-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10221163-B2 Metallo-beta-lactamase inhibitors MLX, ZFX, MMP12 ALDH1A1 259/4885GAA 4/4885CTSL 280/4885
US-20180244656-A1 METALLO-BETA-LACTAMASE INHIBITORS MLX, ZFX, MMP12 ALDH1A1 259/4885GAA 4/4885CTSL 280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.